Ann: ResApp Builds European Market Presence, page-35

Hey all, been a lurker on this and holder since 2018, so not that old, but still seen lots of ups and downs.

I'm not sure why you think RAP can't do both at the moment, as Coivu is Australia and they're also focusing on trying to break into the european market in a significant way. It's a bit unrealistic to expect everyone/anyone to just say i'm going to pay you $$$ without potentially trialling or seeing if the benefits are there for the health system in question. I viewed this as a positive announcement and if the results are close to what we believe they can be, this could be really big step.